July 2017 ENCALS statement on edaravone

Al-Chalabi, A. orcid.org/0000-0002-4924-7712, Andersen, P.M., Chandran, S. et al. (38 more authors) (2017) July 2017 ENCALS statement on edaravone. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. pp. 1-4. ISSN 2167-8421

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http:// creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
Dates:
  • Published: 4 October 2017
  • Accepted: 15 August 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Neuroscience (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 17 Oct 2017 10:47
Last Modified: 17 Oct 2017 10:47
Published Version: https://doi.org/10.1080/21678421.2017.1369125
Status: Published online
Publisher: Informa Healthcare
Refereed: Yes
Identification Number: https://doi.org/10.1080/21678421.2017.1369125
Related URLs:

Share / Export

Statistics